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ABSTRACT
Cardiovascular disease is the leading cause of
death worldwide. Acute aortic syndromes,
which include aortic dissection, intramural
hematoma, and penetrating aortic ulcer,
represent the most morbid presentations of
aortic disease and can be difficult to diagnose.
Recent advances in imaging have allowed for
more rapid and accurate diagnosis of acute
aortic syndromes and the options for
management are expanding. This case report
and review presents the case of a 43-year-old
man with acute type B aortic dissection who
underwent two endovascular procedures for
malperfusion syndrome. The review focuses on
the presentation, diagnosis, medical
management, and procedural options for acute
dissection of the descending aorta.
Keywords: Aortic dissection; Endovascular;
Hypertension; Type B aortic dissection
INTRODUCTION
Cardiovascular disease is the leading cause of
death worldwide [1]. Acute aortic syndromes,
which include aortic dissection, intramural
hematoma, and penetrating aortic ulcer,
represent the most morbid presentations of
aortic disease and can be difficult to diagnose
[2, 3]. Approximately 40% of patients with
acute aortic dissection die before reaching the
hospital [4] with in-hospital early mortality of
1–2% per hour for those who do survive to
hospital-level care [5]. Recent advances in
imaging have allowed for more rapid and
accurate diagnosis of acute aortic syndromes
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and the options for management are
expanding. This case report and review of the
literature will focus on the presentation,
diagnosis, medical management, and
procedural options for acute dissection of the
descending aorta.
The authors conformed with the Helsinki
Declaration of 1975, as revised in 2000
concerning Human and Animal Rights.
Springer’s policy concerning informed consent
has been followed. This article does not contain
any studies with human or animal subjects
performed by any of the authors.
CASE PRESENTATION
A 43-year-old man with a history of cocaine and
amphetamine use and no medical contact since
childhood presented to an outside hospital with
severe, acute-onset, tearing back and flank pain.
On initial evaluation his blood pressure was
240/130 mmHg with a heart rate of 100 beats
per minute and he was noted to have an altered
mental status. Computerized tomography (CT)
angiography at the outside hospital
demonstrated a descending aortic dissection.
He received an intravenous labetalol bolus
followed by continuous infusions of esmolol
and nitroprusside. He was transferred to our
institution for further management.
On arrival, the heart rate was 91 beats per
minute and noninvasively measured blood
pressure was 139/66 mmHg in both arms. The
radial, dorsalis pedis, and posterior tibialis pulses
were full and equal bilaterally. Laboratory
evaluation was notable for potassium of
5.9 mmol/L, creatinine of 1.57 mg/dL, lactic
acid of 2.9 mg/dL, white blood cell count of
20.17 9 103/lL, and a mild troponin-T elevation
at 0.06 ng/mL (Table 1). The electrocardiogram
showed sinus rhythm at a rate of 63 beats per
Table 1 Initial laboratory results
Test Result Reference
range
Sodium (mmol/L) 136 135–145
Potassium (mmol/L) 5.9 3.5–5.0
Chloride (mmol/L) 99 98–108
Bicarbonate (mmol/L) 24 23–32
Blood urea nitrogen (mg/dL) 30 9–25
Creatinine (mg/dL) 1.57a 0.7–1.3







Alkaline phosphatase (U/L) 69 35–130
Total bilirubin (mg/dL) 0.5 0–1




Troponin-T (ng/mL) 0.06 0.00



















Hematocrit (%) 46.1 40–54
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minute with left axis deviation as well as an R
wave in aVL measuring 14 mm, consistent with
left ventricular hypertrophy. Urine toxicology
screen was positive for amphetamines,
tetrahydrocannabinol, and opiates (the latter
had been administered prior to transfer).
Review of the CT obtained at the hospital of
first presentation revealed a descending aortic
dissection that began distal to the origin of the
left subclavian artery and extended to both iliac
arteries (Fig. 1). The left renal artery received
blood supply from the false lumen, which
compressed the true lumen at the site of the
right renal artery takeoff. There was lack of
contrast enhancement of the left kidney
consistent with malperfusion. Enhancement of
the right kidney was normal.
Following multidisciplinary evaluation,
consensus was reached that the time for
surgical intervention to preserve the left
kidney had passed. It was noted that the right
kidney appeared to be perfused and the left
kidney had a warm ischemic time of
approximately 12 h. Given the duration of
warm ischemic time and lack of evidence
of other limb or visceral malperfusion, surgical
intervention was deemed unlikely to be
beneficial and intensive medical management
was recommended. Medical therapy was
selected with careful monitoring of renal
function and visceral and extremity perfusion.
The infusions of esmolol and nitroprusside were
uptitrated and the patient was given
hydromorphone and fentanyl for pain. He was
intubated for airway protection in the setting of
altered mental status and was monitored in the
cardiac intensive care unit with goal heart rate
\60 beats per minute and goal systolic blood
pressure 100–120 mmHg.
Despite control of heart rate and blood
pressure, the urine output declined to \20 cc/
h and creatinine rose to 2.9 mg/dL within the
first 24 h. It was felt that expansion of the false
lumen with compression of the true lumen was
leading to malperfusion of the right kidney. In
addition, he was noted to have diminished
pulses in the right foot. After multidisciplinary
consultation, the decision was made to proceed
with aortic fenestration with the goal of
decompressing the false lumen to restore flow
to the right kidney (Fig. 2, Movie 1). The right
renal artery pressure was lower than the
proximal aorta pressure with a peak gradient
of 50 mmHg and mean gradient of 22 mmHg.
Intravascular ultrasound (IVUS) of the aortic
true lumen showed it to be severely compressed
in the suprarenal segment with a dynamic
component. Fenestration was performed using
a Pioneer Plus catheter (Medtronic
CardioVascular, Santa Rosa, CA) and dilations
across the dissection flap were performed with
10 and 14 mm balloons. Intravascular




Platelet count (91,000/mL) 290 150–450
International normalized ratio 1.0
Partial thromboplastin time (s) 28.1 23.8–36.6




Urine sediment (number per
high power ﬁeld)
4 red blood cells




a No baseline creatinine was available
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and a patent right renal artery. The urine output
increased to 60 cc/h over the next 4 hours.
Despite the initial improvement in renal
function, the urine output again declined to
\30 cc/h with progression to anuria over the
subsequent 8 h. The patient was taken back to
the catheterization laboratory 12 h after the first
procedure. IVUS of the aorta showed that in the
thoracic aorta the true lumen was widely patent
but in the sub-diaphragmatic segment at the
level of the visceral vessels the true lumen
became quite small before enlarging again in
the infrarenal aorta. An endovascular
endarterectomy from T11 to the aortic
bifurcation was undertaken (Fig. 3) with
restoration of flow to the right renal artery.
Urine output post-procedure was 400 cc/h for
the next hour and then returned to baseline.
The remainder of the hospital course was
complicated by ventilator-associated pneumonia,
right internal jugular vein thrombosis, and new-
onset left arm weakness with magnetic resonance
imaging of the brain demonstrating likely embolic
infarcts in the right middle cerebral artery
territory. The patient was successfully extubated
and transitioned to oral medications to control the
blood pressure and heart rate. No embolic source
was found and the left arm weakness had markedly
improved by discharge on hospital day 20. The
creatinine, which had peaked at 3.36 mg/dL on
hospital day three, had declined to 1.3 mg/dL by
discharge. At follow-up, the patient was compliant
with a stable regimen of metoprolol,
hydrochlorothiazide, lisinopril, and amlodipine
to maintain a normal blood pressure and had not
used cocaine or amphetamines since discharge.
Fig. 1 CT angiogram. There is a type B aortic dissection
(Panel A, blue arrows) extending from just below the left
subclavian artery to the proximal iliac arteries. The left main
renal artery arises from the false lumen. A supernumerary left
renal artery arises from the true lumen of the aorta and supplies
a segment of that kidney (Panel B, blue arrow). The right renal
artery is supplied by the true lumen, which is compressed by the
false lumen at the site of the right renal artery takeoff
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The creatinine stabilized between 1.3 and 1.5 mg/
dL. Contrast enhanced CT scan performed three
and a half months after discharge (Fig. 4)
demonstrated a stable dissection beginning
immediately distal to the left subclavian artery
and extending to the distal thoracic aorta without
involvement of the great vessels. The upper pole of
the left kidney was infarcted and atrophied. The
proximal abdominal aortic dimensions remained
stable at 3.3 9 3.3 cm.
PATHOPHYSIOLOGY
AND CLASSIFICATION
Aortic dissection is a disease of the media layer
of the vessel. Bleeding into and along the media
causes a separation of the layers of the aorta [4].
An intimal tear is typically present with a
dissection flap separating the true lumen of
the aorta from the newly created false lumen
[6]; however, intramural hemorrhage may be
present without intimal tear [4]. Spread of the
dissection may proceed in an antegrade or
retrograde direction, or both, and has the
potential to involve branch vessels as well as
cardiac structures.
Degeneration of the aortic media has long
been considered the central underlying process
in aortic dissection, intramural hematoma, and
aneurysm formation [3, 7, 8]. Numerous factors
lead to medial degeneration, including
atherosclerosis, hypertension, tobacco use,
genetic syndromes, and inflammatory
aortopathies, with the end result of increased
wall stress as indicated by the law of La Place. This
relationship, written as r = P 9 r/h, where r is
wall stress, P is luminal pressure, r is vessel radius,
and h is wall thickness [9], demonstrates how
hypertension, aortic dilatation, and decreased
wall thickness all contribute to increased levels
of stress. The law of La Place additionally shows
the particularly detrimental effect of
atherosclerosis, which causes medial necrosis
and thinning by limiting the supply of oxygen
and nutrients and leads to increased radius
through aneurysmal dilatation. When
hypertension and atherosclerosis coexist, as they
frequently do, all three variables contributing to
wall stress have been detrimentally modified.
Fig. 2 Balloon fenestration of the descending aortic ﬂap.
Vascular access was obtained via the right common femoral
artery. The right renal artery was ﬁrst engaged and the
pressure was 50 mmHg lower than in the proximal aorta,
with a mean pressure gradient of 22 mmHg. The vessel
itself was patent on selective right renal artery injection.
Intravascular ultrasound (IVUS) of the aortic true lumen
showed it to be severely compressed in the suprarenal
segment with a dynamic component. Using a 6 F Pioneer
Plus catheter (Medtronic CardioVascular, Santa Rosa, CA)
a puncture was made from the true lumen to the false
lumen during visualization with IVUS. A coronary wire
was advanced into the false lumen all the way to the origin
of the left subclavian artery where it stopped. Fenestration
with 10 and 14 mm balloons followed (Movie 1). Repeat
IVUS of the true lumen showed it to be markedly
expanded and a large gap in the ﬂap just below the origin
of the renal artery was visualized. IVUS of the right renal
artery showed it to be patent. Repeat measurement of
pressure in the renal artery showed that the mean gradient
had decreased to 16 mmHg. Normal ﬂow was seen in the
celiac and mesenteric arteries after fenestration (Panel A)
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Aortic dissection is typically classified
according to location. De Bakey’s original
system [10] based on the site of origin and
extent of dissection has largely been supplanted
by the Stanford system [11], which classifies
according to involvement of the ascending
aorta. Stanford type A includes all dissections
involving the ascending aorta, regardless of the
site of origin. Stanford type B dissections are
confined to the descending aorta. A spectrum of
aortic abnormality is now recognized including
intramural hematoma and penetrating aortic
ulcer in addition to classic aortic dissection; the
Svensson system assigns acute aortic syndromes
to one of five classes (Table 2) [12, 13]. The
patient presented here had a Stanford type B,
Svensson Class 1 aortic dissection.
EPIDEMIOLOGY AND RISK
FACTORS
The incidence of aortic dissection in developed
countries is approximately three events per
100,000 person-years [14]. Aortic dissection
occurs with a bimodal age distribution. Among
older patients, the most prevalent risk factors
are hypertension, atherosclerosis, male gender,
aortic aneurysm, smoking, and prior
cardiovascular operations [15, 16] (Table 3).
The greatest risk factor for aneurysm is
atherosclerosis [17]. Among younger patients,
genetic causes such as Marfan’s syndrome,
Ehlers–Danlos syndrome (type IV), Loeys–Dietz
syndrome, Turner syndrome, aortic coarctation,
bicuspid aortic valve, and non-syndromic
familial dissection are the predominant risk
factors [3, 18]. A full 50% of patients aged less
than 40 years with aortic dissection have
Fig. 3 Endarterectomy and stenting of the descending
aortic ﬂap. Vascular access was obtained via the right
common femoral artery. Wires were placed in both the
true aortic lumen and the false lumen under intravascular
ultrasound (IVUS) guidance via the external iliac artery.
IVUS of the aorta showed that in the thoracic aorta the
true lumen was widely patent and large in caliber. In the
sub-diaphragmatic segment at the level of the visceral
vessels the true lumen became quite small before enlarging
again in the infrarenal aorta (Panel A). An endovascular
endarterectomy was performed from T11 to the aortic
bifurcation. A 6 F Pioneer Plus IVUS reentry catheter
(Medtronic CardioVascular, Santa Rosa, CA) was used to
create a path from the true lumen to the false lumen at
T11 (Movie 1). This wire spanning both lumens was
snared in the false lumen using a catheter advanced from
the right common femoral artery. Both ends of a 0.02500
Terumo guide wire (Terumo Europe N.V., Leuven,
Belgium) were externalized and pulled together to the iliac
bifurcation to perform the endarterectomy (Movie 2).
IVUS of the aorta showed that the infra-diaphragmatic
aorta now comprised a single lumen. The right renal artery
and mesenteric vessels ﬁlled briskly but the aorta was
occluded at the just below the inferior mesenteric artery as
a result of functional endarterectomy of the infra-
diaphragmatic aorta. Two 8 9 57 mm VisiProTM bal-
loon-expandable peripheral stents (Covidien, Dublin,
Ireland) were deployed in a kissing fashion, extending
from the infrarenal aorta into the right and left common
iliac arteries. They were postdilated with 10 and 12 mm
balloons. Further overlapping stenting was required to
maintain adequate distal ﬂow. Femoral and pedal pulses
were bounding post-procedure
b
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Marfan’s syndrome [19]. Inflammatory
aortopathies such as Takayasu arteritis and
giant cell arteritis additionally predispose to
aortic syndromes. Dilatation of the ascending
aorta and aortic arch as well as aortic tortuosity
are newly described anatomic predictors of type
B dissection among patients with hypertension
[20].
The International Registry of Acute Aortic
Dissection (IRAD) was formed in 1996 to track
the presentation, diagnosis, management, and
outcomes of patients with acute aortic
dissection at 25 referral centers in 12 countries
[21]. Among this cohort, 65% of patients were
males with a mean age of 63 years. Nearly three
quarters carried a diagnosis of hypertension,
31% had known atherosclerosis, and 18% had
undergone prior cardiac surgery. Four percent
had Marfan’s syndrome [21]. Thirty-eight
percent of dissections were Stanford type B.
Overall mortality was approximately 23% in the
IRAD registry, but was 40% among patients who
had used cocaine prior to dissection [21].
Among patients with type B dissection, overall
mortality was 12%, with 20% mortality among
those with complications and 6% mortality in
uncomplicated cases [22]. Mortality does not
appear to be significantly different between
acute type B dissection and type B intramural
hematoma [23].
Based on these data, our patient was typical
in his gender and predisposing hypertension,
but was at increased risk for mortality given his
renal injury and stimulant use. His relative
Table 2 Svensson system for classiﬁcation of aortic
dissection
Class 1: Classic dissection with intimal ﬂap separating
true and false lumens
Class 2: Intramural hematoma
Class 3: Limited intimal tear with eccentric bulge
Class 4: Penetrating atherosclerotic ulcer
Class 5: Iatrogenic dissection
Classiﬁcation of aortic dissection as outlined by Svensson
et al. [12]
Fig. 4 Follow-up CT scan. CT scan obtained three and a
half months after discharge demonstrated a Stanford type B
aortic dissection with the intimal ﬂap originating just distal
to the origin of the left subclavian artery and extending to
the descending portion of the thoracic aorta (Panel A, 3D
reconstruction, blue arrow). There was no involvement of
the great vessels. A marked perfusion defect in the upper
pole of the left kidney with associated interval atrophy of
the left upper pole was seen (Panel B, blue arrow).
Unchanged aneurysmal dilatation of the proximal abdom-
inal aorta, measuring 3.3 9 3.3 cm, was present
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youth raises the possibility of an underlying
vasculopathy, but he had clear predisposing risk
factors for dissection and no other evidence to
suggest a syndromic process.
PRESENTATION
The spectrum of presentation of acute aortic
dissection is protean, requiring vigilance on the
part of the provider to arrive at the diagnosis
promptly. Given the frequently non-specific
presentation and higher pre-test probability of
more common processes, acute aortic dissection
is not diagnosed on initial evaluation in 38% of
patients [24]. Common symptoms and signs
include abrupt onset chest and/or back pain
(86%) with radiation to the shoulders or neck
that is typically described as tearing/sharp
(64%), hypertension (69%), pulse deficit
(20–30%), and syncope (13%) [16, 21, 24]. Less
common presentations include heart failure
symptoms, abdominal pain, spinal cord
involvement with neurological deficits, Horner
syndrome, and vocal cord paralysis [9]. Painless
presentation is also observed in approximately
4–5% of patients and is associated with worse
prognosis, perhaps related to delay in diagnosis
[21].
The patient discussed here presented with
acute, tearing back and flank pain as well as
hypertension, allowing prompt consideration
of the correct diagnosis.
DIAGNOSIS
The principle approach to the diagnosis of acute
aortic syndromes is radiographic, though
biochemical assays are an area of active
research. The electrocardiogram (ECG) can be
helpful in detecting rare complications such as
coronary involvement; however, it is frequently
abnormal and is not specific for acute aortic
syndromes [24, 25].
The goals of aortic imaging are fourfold,
namely to (1) establish the diagnosis, (2)
localize the intimal tear, (3) determine the
Table 3 Risk factors for aortic dissection
Conditions associated with increased aortic wall stress
Hypertension, particularly if poorly controlled
Pheochromocytoma
Cocaine or other stimulant use
Weight lifting or other Valsalva maneuver
Trauma
Deceleration or torsional injury
Coarctation of the aorta
Conditions associated with aortic media abnormalities
Genetic
Marfan’s syndrome
Ehlers–Danlos syndrome, vascular form













Chronic corticosteroid or immunosuppressant
administration
Infections involving the aortic wall
Risk factors for aortic dissection as described by Hiratzka
et al. [4]
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extent of dissection, and (4) assess for indicators
of pending emergency [9]. The modalities
available for definitive imaging include
computerized tomography angiography (CTA),
magnetic resonance imaging (MRI),
transesophageal echocardiography (TEE), and,
less commonly, aortography. Among the IRAD
cohort, CTA was performed in 93% of cases, TEE
in 59%, MRI in 31%, and aortography in 24%
[16]. Often times more than one study is
necessary to confirm and fully characterize the
diagnosis; thus the mean number of imaging
studies other than plain film performed per
patient is 1.8 [24].
Transthoracic echocardiography (TTE)
provides a rapid tool for assessing cardiac
complications of type A dissection such as wall
motion abnormalities indicative of coronary
artery involvement, pericardial tamponade,
and aortic insufficiency [26]. TTE provides
minimal to no imaging of the distal
ascending, transverse, and descending aorta
and is typically used in conjunction with TEE
or another imaging modality. TEE can be
rapidly obtained in many circumstances and
has the advantages of excellent visualization of
the distal ascending, transverse, and descending
aorta, ability to differentiate between true and
false lumens, and identification of intramural
hemorrhage and penetrating atherosclerotic
ulcer. TEE is limited by its invasive nature
requiring sedation and a contraindication in
significant esophageal disease, such as varices
[27]. When combined with TTE, TEE achieves a
sensitivity of 99% and specificity of 89% [28] for
aortic dissection.
CT imaging with intravenous contrast can be
rapidly performed in most Emergency
Departments and has a sensitivity of at least
95% and specificity between 85% and 100% [9,
29, 30]. The disadvantages of CT are the
contrast load in patients who already have or
may develop acute kidney injury as a result of
the underlying process and limited ability to
identify the site of intimal tear [9, 31].
MRI has perhaps the highest sensitivity and
specificity, approaching 100% for each [27, 29,
32]. MRI has the additional advantages of not
requiring intravenous contrast injection for
vessel visualization and not exposing the
patient to ionizing radiation [27]. Its use is
constrained by the factors that limit MRI use in
other settings, which are lack of availability,
length of time for image acquisition in
potentially unstable patients, patient
discomfort/anxiety, and contraindication in
patients with metallic implants (e.g., most
pacemakers and implantable cardioverter-
defibrillators).
Given that TEE, CT, and MRI all have
favorable test characteristics, the choice of
imaging modality largely depends on local
availability and time. CT is nearly universally
available in the developed world, is non-
invasive, and is rapid, and, therefore, is the
preferred modality in many institutions [16].
However, some institutions practice routine TEE
in patients with proximal dissections. The
American Heart Association (AHA)
recommends TEE as the first imaging study in
unstable patients to prevent patient transport
out of the acute care setting [4].
Biochemical markers of aortic dissection
remain largely investigational. Candidate
markers include lactate dehydrogenase,
d-dimer, white blood cell count, c-reactive
protein, fibrinogen, and circulating smooth
muscle myosin heavy chain. Currently, there
is no clinically available biochemical assay
specific for aortic dissection [4].
The patient described here had CT
angiography performed on presentation to the
referring hospital, which accurately identified the
type B aortic dissection and branch vessel
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involvement. Transesophageal echocardiography
would have been a reasonable initial study as well
given the need for close hemodynamic
management and the elevated creatinine.
MANAGEMENT
The initial goals in management are to (1)
decrease the shear stress on the aortic wall by
limiting the force of left ventricular
contraction; (2) minimize total wall stress by
decreasing blood pressure to the extent allowed;
and (3) maintain adequate end organ perfusion.
Beta-blockers such as metoprolol, esmolol,
propranolol, and labetalol are administered as
first-line agents with goal heart rate \60 beats
per minute and goal systolic blood pressure
between 100 and 120 mmHg (Table 4) [4, 9, 26].
In patients who are intolerant of beta-
adrenergic blockade, non-dihydropyridine
calcium channel blockers may be an effective
alternative [4, 9]. Vasodilators such as sodium
nitroprusside, and nitroglycerin, or
dihydropyridine calcium channel blockers are
employed if beta blockade fails to adequately
control blood pressure, but should not be used
prior to heart rate control or as single agents
given their propensity to increase the left
ventricular contractile force and cause reflex
tachycardia [4, 26]. Pain control is an important
aspect of heart rate and blood pressure
management and is typically achieved with
morphine sulfate or another narcotic [4, 9].
There are no randomized trials comparing
medical management strategies for acute type
B dissection [4].
Uncomplicated type B dissection should be
managed medically with close monitoring for
the development of complications [33]. For
patients with extant or impending
complication, endovascular and/or surgical
management should be considered. In the
IRAD registry, 73% of patients with acute type
B dissection were managed medically, 15%
received a surgical intervention, and 12%
received a percutaneous intervention [16].
In-hospital mortality for patients with
ischemic complications managed surgically
was historically observed to be as high as 89%,
prompting interest in less invasive techniques
Table 4 Initial medical management of heart rate and
blood pressure in acute aortic dissection
Agent Dose
Beta blockers
Esmolol 0.5–1 mg/kg bolus followed by
continuous infusion at 0.10–0.20 mg/
kg/min
Propranolol 0.05–0.15 mg/kg bolus every 4–6 h
Metoprolol 1.25–15 mg bolus every 3–12 h
Combined alpha and beta blocker
Labetalol 0.25–0.5 mg/kg bolus followed by
continuous infusion at 2.0–6.0
mg/min
Non-dihydropyridine calcium channel blockers
Verapamil 2.5–5 mg bolus followed by continuous
infusion at 5–24 mg/h
Diltiazem 0.25–0.35 mg/kg bolus followed by




0.25–10 lg/kg/min continuous infusion
Nitroglycerin 5–100 lg/min continuous infusion
Fenoldopam 0.01–1.6 lg/kg/min continuous
infusion
Dihydropyridine calcium channel blocker
Nicardipine 5–15 mg/h continuous infusion
Guidelines regarding the medical management of aortic
dissection as described by Hiratzka et al. [4] and Erbel
et al. [9]
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[9, 34]. The first endovascular intervention for
acute type B dissection was a balloon
fenestration of the intimal flap in a patient
with visceral ischemia performed in 1990 [35].
Endovascular techniques now provide an
expanding range of interventions, including
fenestration, covered stents at the site of
dissection entry, ballooning and stenting at
sites of complications, and stent-graft
placement such as thoracic endovascular aortic
repair (TEVAR). Often, a combination of these
techniques is employed to provide rapid
amelioration of static or dynamic obstruction
of the true lumen with organ hypoperfusion.
No completed randomized trials compare
medical, endovascular, and/or surgical
approaches among patients with acute type B
dissection [36].
In a composite of 57 patients treated with an
endovascular approach, adequate flow was
restored in 90% of obstructed arteries with an
average 30-day mortality of 10% [9]. A meta-
analysis by Eggebrecht et al. [37] found a 98%
success rate for endovascular stent-graft
placement for acute and chronic type B
dissection with 89% survival at 2 years and an
11% major complication rate. Patel et al.
reviewed outcomes among 69 patients with
acute type B dissection complicated by branch
vessel hypoperfusion treated with flap
fenestration and stenting of the true lumen
and/or branch vessels. Adequate perfusion was
restored to 96% of the affected vascular beds
and mean survival was 84 months [38].
Rates of mortality and major morbidity
appear to be lower with endovascular
procedures compared with surgical
intervention [39], but these data need to be
cautiously interpreted due to the lack of large
randomized trials and the tendency for the
most complicated patients to be referred for
surgical repair [36]. In a 2011 IRAD review,
patients with complicated type B dissections
receiving percutaneous intervention had a 10%
in-hospital mortality as compared with 29% for
those receiving surgery and 21% for those
managed medically alone [22]. Similarly, a
case–control study by Brandt et al. among
patients receiving either open surgery or
endovascular stent-graft repair for dissections
of the descending thoracic aorta found 5%
30-day mortality among the stent-graft group
and 27% mortality among the open surgery
cohort. The rate of post-procedure stroke or
paraplegia was 5% in the stent-graft group and
9% in the surgery group [40]. Finally, in an
IRAD cohort of 571 patients with acute type B
dissection, Fattori et al. [33] observed a 20% in-
hospital complication rate among those
undergoing endovascular repair as opposed to
a 40% in-hospital complication rate among
those treated surgically. While these
observational data show a consistent trend
toward improved outcomes with endovascular
repair, as was previously described,
interpretation needs to account for the
propensity for more complicated patients to be
selected for surgery.
The Investigation of Stent Grafts in Aortic
Dissection (INSTEAD) trial compared elective
TEVAR plus optimal medical management in
stable patients at least 2 weeks following an
acute type B aortic dissection to optimal
medical management alone. At 2 years there
was no difference in all-cause mortality, aorta-
related mortality, or neurologic complications,
although the study was not powered to detect a
difference in clinical events [41]. Interestingly,
aortic remodeling with true lumen recovery and
false lumen thrombosis was observed in 91% of
TEVAR patients and only 19% of the medically
managed cohort. Given the active remodeling
observed, it is perhaps possible that a larger
study population or longer follow-up period
Cardiol Ther (2013) 2:199–213 209
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might reveal a clinical benefit to TEVAR in this
population.
Expert consensus recommends medical
management as the initial approach to
uncomplicated acute type B aortic dissection.
Endovascular or surgical repair should be
considered in the setting of impending aortic
rupture, end-organ hypoperfusion, dissection
extension, hypotension, or failure to control
hypertension or pain [4, 13], with TEVAR
recommended as first line management of
complicated acute type B dissection where
available [33]. This treatment strategy is
elaborated in algorithmic form from the 2013
American College of Cardiology consensus
statement in Table 5 [36] and considerations
for endovascular and surgical repair are
summarized in Table 6 [34].
The patient presented here was initially
managed medically and observed closely for
the development of complications. When renal
and limb hypoperfusion were noted,
consideration was given to surgical and
percutaneous options for intervention. Because
the issue of primary importance at the time of
the first intervention was compression of the
true lumen by the false lumen, and because
endovascular management is associated with
lower morbidity than open procedures, the
decision was made to proceed first with
fenestration with the goal of relieving the
trans-membrane pressure gradient. When this
approach succeeded initially but then failed to
provide a lasting solution, it was felt that
completion of the fenestration with what was
functionally an endarterectomy would provide
definitive relief of flow limitation in the true
lumen. Open axillary-femoral bypass and
TEVAR were also considered, but it was
anticipated that adequate flow could be
restored without the incumbent morbidity of a
more involved open or endovascular
intervention. Given the current landscape of
numerous options for intervention and lack of
definitive evidence for weighing the likelihood
of success and risk of complication, randomized
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trials are needed comparing these techniques to
guide management in situations such as these.
FOLLOW-UP
The most critical issue following the acute
hospitalization is close outpatient
management of blood pressure. Follow-up
imaging is recommended after acute dissection
at 7 days, hospital discharge, 6 weeks,
3 months, 6 months, and 12 months, and then
every 12 months thereafter. Consideration of
imaging modality is similar to that with acute
dissection, save for the improved patient
stability and reduced urgency. Primary
objectives of follow-up imaging are to assess
for aortic expansion, aneurysm, and vascular
leak at sites of intervention [9].
CONCLUSION
The aging populations of developed countries
and the ongoing demographic transitions of
developing nations will likely ensure that
cardiovascular disease remains the leading
cause of morbidity and mortality worldwide
for the near future. Aortic pathology, including
acute aortic dissection, remains an
underappreciated yet important contributor to
this disease burden. Progress continues to be
made in diagnosis and management,
particularly with respect to endovascular
repair. As these techniques evolve, further
comparisons of efficacy and safety will be
needed to guide treatment decisions in this
complicated and frequently unstable patient
group. While population-level reduction of
cardiovascular risk factors is ultimately
required to prevent the development of aortic
disease, high clinical suspicion and prompt
diagnosis remain critical to limit the
devastating sequelae of acute aortic syndromes.
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Table 6 Considerations for surgical, medical, and
interventional therapy in aortic dissection
Medical therapy
Treatment of choice in uncomplicated type B
dissection
Stable, isolated arch dissection
Stable type B dissection (chronic, C2 weeks after
onset)
Interventional therapy
Stent-grafts to seal entry to false lumen and to enlarge
compressed true lumen




Treatment of choice for type A dissection
Consider for acute type B dissection complicated by
Marfan’s syndrome
Rupture or impending rupture (consider
interventional therapy)
Progression or compromise of vital organs (consider
interventional therapy)
Considerations for surgical, medical, and interventional
therapy in aortic dissection as described by Nienaber et al.
[34]
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